SK

Subin Kandathinkarayil Balan

Active Director Director DIN 07931550
DIN 07931550 First appointment Nov 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 2 historical roles
Total affiliations 8 Since Nov 2017
Shareholding value •••• Premium profile

About Subin Kandathinkarayil Balan

Data last updated:

Subin Kandathinkarayil Balan is a Director at Good Hew Meditech Private Limited (since 2018), Designated Partner at 171 Go Llp (since 2026) and Designated Partner at Rasakoot Llp (since 2026), and holds 3 more current directorships. The companies operate in Healthcare, Business Services and Entertainment. The largest current company by reported revenue is Good Hew Meditech Private Limited at ₹29 Lakh (FY 2022). Earlier, Subin Kandathinkarayil Balan was a Director at Beins International Private Limited (2017–2019) and Whole-Time Director at Gambier International Private Limited (2020–2022).

DIN 07931550
Primary Designation Director
Industry Healthcare
First Appointment 24 Nov 2017
Oldest Company Age 8 yrs
Largest company Good Hew Meditech Private Limited · ₹29 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Good Hew Meditech Private Limited U74999KL2018PTC054802
Director21 Sep 20182018₹29 Lakh (FY 2022)Active
171 Go Llp ADC-7852
Designated Partner29 Sep 20262026Active
Rasakoot Llp ADA-9242
Designated Partner05 Aug 20262026Active
171 Talent Factory Private Limited U46909KL2023PTC081600
Director25 May 20232023Active
Basaro Private Limited U46909KL2023PTC081106
Whole-Time Director26 Apr 20232023Active
Director14 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beins International Private Limited U74999KL2017PTC051172
Director24 Nov 20172017₹2.6 Lakh (FY 2025)Active
Whole-Time Director02 Mar 20202020₹1,700 (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Good Hew Meditech Private Limited
Aman Recruitment Consultants Private Limited
Basaro Private Limited
171 Talent Factory Private Limited
Premium access

Shareholding and investment profile for Subin Kandathinkarayil Balan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subin Kandathinkarayil Balan

Subin Kandathinkarayil Balan currently holds 6 directorships: Good Hew Meditech Private Limited (Director, since 21 Sep 2018, revenue ₹29 Lakh (FY 2022)); 171 Go Llp (Designated Partner, since 29 Sep 2026); Rasakoot Llp (Designated Partner, since 05 Aug 2026); 171 Talent Factory Private Limited (Director, since 25 May 2023); Basaro Private Limited (Whole-Time Director, since 26 Apr 2023); and 1 more.

Subin Kandathinkarayil Balan was first appointed on 24 Nov 2017 as Director at Beins International Private Limited. The most recent appointment on record is 29 Sep 2026 at 171 Go Llp.

Subin Kandathinkarayil Balan held 2 earlier board appointments: Beins International Private Limited (Director, 24 Nov 2017 to 14 Dec 2019); Gambier International Private Limited (Whole-Time Director, 02 Mar 2020 to 09 Jun 2022).

The current boards of Subin Kandathinkarayil Balan's companies include Divesh Navinchandra Sheth (Good Hew Meditech Private Limited), Kizhakkeveeettil Shiju (Good Hew Meditech Private Limited), Lakshmi Narasimhan Harish (Good Hew Meditech Private Limited), Vijayan Madhankumar (Good Hew Meditech Private Limited), Jomon James (171 Go Llp), Ratheesh Chandran Puthuvalnirathil Lekshmi Ramachandran (171 Go Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available